FDA Approves Daily Libido Pill for Postmenopausal Women
The U.S. Food and Drug Administration (FDA) has approved a daily pill designed to enhance libido among postmenopausal women, extending access to those up to the age of 65. This…
Bridging the Gap: Real-World Data in Clinical Trials
In the evolving landscape of medical research, the disparity between clinical trial populations and real-world patients has become increasingly apparent. While clinical trials are essential for establishing the safety and…